Gedeon Richter UK has assumed full marketing and distribution responsibilities for the neuropsychiatry medicine cariprazine ...

On Sept. 26, the FDA approved the first truly new antipsychotic in decades: Cobenfy. In clinical trials, it didn’t cause certain side effects that traditionally interfere with medication adherence, ...

Schizophrenia is a highly heterogeneous psychiatric disorder affecting ~1% of the global population, typically emerging in ...

The term "schizophrenia" was unclear in meaning from its beginning and has remained unclear ever since. It is long past time to replace it with better alternatives.

Pea-sized brains grown in a lab have for the first time revealed the unique way neurons might misfire due to schizophrenia and bipolar disorder, psychiatric ailments that affect millions of people ...

Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study ...

A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles of people living with both schizophrenia and a personality disorder. A ...

NEW YORK, Aug. 29 (UPI) --People with schizophrenia have been challenging the ongoing stigma tied to their mental disorder by posting on social media, trying to dispel the myth that they're prone to ...

Periods of hormonal flux, such as pregnancy, postpartum, and menopause, affect disease severity of schizophrenia. In addition to higher rates of comorbidities for themselves and their babies, pregnant ...